Granite Point Capital Management, L.P. Spruce Biosciences, Inc. Transaction History

Granite Point Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.33 - $5.74 $148,220 - $365,144	-63,614 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$6.01 - $11.26 $218,679 - $409,706	-36,386 Reduced 36.39%	63,614 $382,000
Q4 2020 Feb 05, 2021	BUY	$15.38 - $32.42 $1.54 Million - $3.24 Million	100,000 New	100,000 $2.43 Million

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.42M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.